As the trial progresses, the legal teams—Sandoz represented by Alston & Bird LLP and Quinn Emanuel Urquhart & Sullivan LLP, and United Therapeutics by Williams & Connolly LLP and Blank Rome LLP—will continue to unveil the complexities of this significant case, which could have far-reaching implications for the pharmaceutical industry.
The case, officially titled Sandoz Inc. et al. v. United Therapeutics Corp. et al., is documented under case number 2:19-cv-10170 in the U.S. District Court for the District of New Jersey.
